Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Jordan

Jordan

The Treatment of Cardiovascular Diseases market in Jordan is expected to witness significant growth in the coming years.
According to projections, the revenue is projected to reach US$166.80m in 2024.
Furthermore, it is anticipated that the market will experience a steady annual growth rate of 4.58% between 2024 and 2029, resulting in a market volume of US$208.70m by the end of 2029.
In global comparison, United States is expected to generate the highest revenue in the Treatment of Cardiovascular Diseases market, with an estimated revenue of US$136.00bn in 2024.
This indicates the dominance of the United States in this market.
Jordan is investing heavily in advanced medical technologies and facilities to improve the treatment of cardiovascular diseases.

Key regions: Germany, France, Japan, Europe, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.